BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29425663)

  • 1. Sexual Rehabilitation After Nerve-Sparing Radical Prostatectomy: Free-of-Charge Phosphodiesterase Type 5 Inhibitor Administration Improves Compliance to Treatment.
    Siena G; Mari A; Canale A; Mondaini N; Chindemi A; Greco I; Saleh O; Serni S; Nicita G; Minervini A; Carini M
    J Sex Med; 2018 Feb; 15(2):120-123. PubMed ID: 29425663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
    Basal S; Wambi C; Acikel C; Gupta M; Badani K
    BJU Int; 2013 Apr; 111(4):658-65. PubMed ID: 23186312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis.
    Limoncin E; Gravina GL; Corona G; Maggi M; Ciocca G; Lenzi A; Jannini EA
    Andrology; 2017 Sep; 5(5):863-872. PubMed ID: 28787547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy.
    Kimura M; Caso JR; Bañez LL; Koontz BF; Gerber L; Senocak C; Donatucci CF; Vujaskovic Z; Moul JW; Polascik TJ
    BJU Int; 2012 Dec; 110(11 Pt C):E931-8. PubMed ID: 22520165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
    Polito M; d'Anzeo G; Conti A; Muzzonigro G
    BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penile rehabilitation for postprostatectomy erectile dysfunction.
    Philippou YA; Jung JH; Steggall MJ; O'Driscoll ST; Bakker CJ; Bodie JA; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012414. PubMed ID: 30352488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency.
    Lee DJ; Cheetham P; Badani KK
    BJU Int; 2010 Feb; 105(3):382-8. PubMed ID: 19747355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of penile rehabilitation with phosphodiesterase-5 inhibitors on recovery of erectile function in patients undergoing robot-assisted radical prostatectomy: A propensity score-matched analysis.
    Kimura Y; Honda M; Teraoka S; Yumioka T; Iwamoto H; Morizane S; Hikita K; Takenaka A
    Int J Urol; 2021 Jun; 28(6):637-642. PubMed ID: 33663015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
    Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
    BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial.
    Baccaglini W; Pazeto CL; Corrêa Barros EA; Timóteo F; Monteiro L; Saad Rached RY; Navas A; Glina S
    J Sex Med; 2020 Apr; 17(4):688-694. PubMed ID: 32007430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.
    Cathala N; Mombet A; Sanchez-Salas R; Rozet F; Barret E; Giuliano F; Galiano M; Prapotnich D; Kazzazi A; Djavan B; Jaffe J; Cathelineau X; Vallancien G
    Can J Urol; 2012 Aug; 19(4):6328-35. PubMed ID: 22892254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Starting Penile Rehabilitation with Sildenafil Immediately after Robot-Assisted Laparoscopic Radical Prostatectomy on Erectile Function Recovery: A Prospective Randomized Trial.
    Jo JK; Jeong SJ; Oh JJ; Lee SW; Lee S; Hong SK; Byun SS; Lee SE
    J Urol; 2018 Jun; 199(6):1600-1606. PubMed ID: 29307683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penile Rehabilitation Therapy Following Radical Prostatectomy: A Meta-Analysis.
    Liu C; Lopez DS; Chen M; Wang R
    J Sex Med; 2017 Dec; 14(12):1496-1503. PubMed ID: 29122494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
    Mulhall JP; Brock G; Oelke M; Fode M; Probst KA; Henneges C; d'Anzeo G; Rossi A; Büttner H
    J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life, Psychological Functioning, and Treatment Satisfaction of Men Who Have Undergone Penile Prosthesis Surgery Following Robot-Assisted Radical Prostatectomy.
    Pillay B; Moon D; Love C; Meyer D; Ferguson E; Crowe H; Howard N; Mann S; Wootten A
    J Sex Med; 2017 Dec; 14(12):1612-1620. PubMed ID: 29111200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.
    Loeb S; Folkvaljon Y; Robinson D; Schlomm T; Garmo H; Stattin P
    Eur Urol; 2016 Nov; 70(5):824-828. PubMed ID: 26743040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Kiel Concept" of Long-Term Administration of Daily Low-Dose Sildenafil Initiated in the Immediate Post-Prostatectomy Period: Evaluation and Comparison With the International Literature on Penile Rehabilitation.
    Osmonov DK; Jünemann KP; Bannowsky A
    Sex Med Rev; 2017 Jul; 5(3):387-392. PubMed ID: 28372960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' desire to preserve sexual activity and final decision for a nerve-sparing approach: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.
    Imbimbo C; Creta M; Gacci M; Simonato A; Gontero P; de Cobelli O; Briganti A; Fulcoli V; Martorana G; Nicita G; Mirone V; Carmignani G
    J Sex Med; 2011 May; 8(5):1495-502. PubMed ID: 21324091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.